A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of ...
Sep 20, 2021
0
89
Individuals at higher risk of developing pancreatic cancer could be identified earlier using machine learning (ML) techniques which would result in a greater number of patients surviving the disease, suggests a new study ...
Jun 2, 2021
0
22
A new study exploits the characteristic epigenetic signatures of childhood tumors to detect, classify and monitor the disease. The scientists analyzed short fragments of tumor DNA that are circulating in the blood. These ...
May 28, 2021
0
23
To improve diagnosis for patients with complex metastatic cancers, especially those in low-resource settings, researchers from the Mahmood Lab at the Brigham and Women's Hospital developed an artificial intelligence (AI) ...
May 5, 2021
0
61
Like Peter Pan, some cells never grow up. In cancer, undifferentiated stem cells may help tumors such as glioblastoma become more aggressive than other forms of the disease. Certain groups of genes are supposed to help cells ...
Jan 8, 2021
0
50
The first comprehensive study of DNA changes in healthy and diseased human bladder tissue has revealed that 'cancer-driving' mutations are common in healthy bladder tissue. The study, conducted by scientists at the Wellcome ...
Oct 1, 2020
0
34
Oesophageal cancer is the eighth most common cancer worldwide. It often develops from a condition called Barrett's oesophagus. Existing monitoring and treatment methods are very intrusive, and many patients have to undergo ...
Sep 7, 2020
0
144
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. ...
Aug 17, 2020
0
33
Considered the "guardian of the genome," TP53 is the most commonly mutated gene in cancer. TP53's normal function is to detect DNA damage and prevent cells from passing this damage on to daughter cells. When TP53 is mutated, ...
Aug 3, 2020
0
140
Researchers at EMBL's European Bioinformatics Institute (EMBL-EBI), the Wellcome Sanger Institute, Addenbrooke's Hospital in Cambridge, UK, and collaborators have developed an artificial intelligence (AI) algorithm that uses ...
Jul 28, 2020
0
128
